美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

KraneShares MSCI All China Health Care Index ETF

18.09

-0.3900-2.11%

盘后：18.090.00000.00%16:10 EDT

成交量：3.58万

成交额：64.89万

市值：1.10亿

市盈率：- -

高：18.37

开：18.37

低：18.04

收：18.48

52周最高：19.93

52周最低：14.38

股本：609.92万

流通股本：609.92万

量比：0.17

换手率：0.59%

股息：0.72

股息率：3.96%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

港股异动 | CRO概念股涨幅居前花旗指美对华药企授权政策前景偏正面继续看好创新药及生物科技

药明生物(02269)出现大手卖出15.9万股，成交价$53.05，涉资843.495万

阿斯达克财经

AI医疗概念股盘初多股扬升金斯瑞生物科技（01548）领涨7.05%

【湾区早参】8月香港整体出口和进口货值分别上升53.0%和60.0%；深圳推动“好房子”建设提质增效

智通港股早知道 | 监管明确险资投资港股通ETF口径海光芯正(01191)南向持股占比升至4.2%

深度｜中国创新药的命题：原始创新与全球重磅品种如何突围

石药集团(01093)：JMT101联合奥希替尼一线治疗携带EGFR20号外显子插入突变的局部晚期或转移性非小细胞肺癌的Ⅲ期临床试验取得阳性顶线结果

石药集团：Becotatug（JMT101）联合奥希替尼III期试验取得积极顶线结果

石药集团(01093.HK)：注射用多西他赛(白蛋白结合型)(HB1801)用于治疗晚期乳腺癌的Ⅲ期临床试验在中国正式启动

生物医药板块全线走低诺诚健华（09969）跌10.48% 机构指行业需求尚未明显回暖

信达生物(01801)出现大手卖出10.75万股，成交价$100.0，涉资1.075千万

阿斯达克财经

药明生物(02269)出现大手卖出10.05万股，成交价$52.25，涉资525.112万

阿斯达克财经

【券商聚焦】国金证券：跨赛道巨头竞速AI4S制药，板块成长趋势进一步确立

【券商聚焦】国金证券：中国双抗/ADC/小核酸具全球竞争力，有望催化创新药新一轮出海与估值重估

港股医药实力抗跌！CXO再扛旗，核心ETF（159137）逆市收红，金斯瑞创5年新高！两个问题引发关注……

【天风医药杨松团队|公司点评】信达生物：肿瘤与综合产品线双轮驱动，业绩保持强劲增长

百济神州(06160)出现大手买入2.74万股，成交价$217.4，涉资595.676万

阿斯达克财经

A股医药板块全线爆发，发生了什么？

康方生物(09926)出现大手卖出6.9万股，成交价$100.0，涉资690万

阿斯达克财经

国金证券：中国创新药密集登场成肺癌前沿焦点 ADC治疗线数持续前移

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/KURE/news?page=7"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.09,"timestamp":1791921600000,"preClose":18.48,"halted":0,"volume":35825,"hourTrading":{"tag":"盘后","latestPrice":18.09,"preClose":18.09,"latestTime":"16:10 EDT","volume":3,"amount":54.269999999999996,"timestamp":1791922205029,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.021103896103896135,"floatShares":6099205,"shares":6099205,"eps":0,"marketStatus":"盘后交易","change":-0.39,"latestTime":"10-13 17:13:57 EDT","open":18.37,"high":18.37,"low":18.04,"amount":648889,"amplitude":0.017857,"askPrice":18.33,"askSize":1,"bidPrice":16.51,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791936000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.48,"sharesOutstanding":4750002,"nav":18.56,"aum":113201248.34,"dividendRate":0.039569,"bidAskSpread":0.004047,"postHourTrading":{"tag":"盘后","latestPrice":18.09,"preClose":18.09,"latestTime":"16:10 EDT","volume":3,"amount":54.269999999999996,"timestamp":1791922205029,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.168719,"impliedVol":0.3311,"impliedVolPercentile":0.6773},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":6099205,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.168719,"shares":6099205,"dividePrice":0.7158,"high":18.37,"amplitude":0.017857,"preClose":18.48,"low":18.04,"week52Low":14.3797,"pbRate":"--","week52High":19.93,"institutionHeld":0,"latestPrice":18.09,"committee":0.980198,"eps":0,"divideRate":0.039569,"volume":35825,"delay":0,"ttmEps":0,"open":18.37,"prevYearClose":17.04,"prevWeekClose":18.72,"prevMonthClose":19.25,"prevQuarterClose":19.25,"fiveDayClose":19.49,"twentyDayClose":17.97,"sixtyDayClose":17.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670448333","title":"港股异动 | CRO概念股涨幅居前 花旗指美对华药企授权政策前景偏正面 继续看好创新药及生物科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2670448333","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670448333?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 13:50","pubTimestamp":1790315418,"startTime":"0","endTime":"0","summary":"与美国国会部分议员此前主张的广泛限制不同，正在讨论的方案可能重点限制病原体以及可能被武器化的生物技术。花旗发表发布研报称，该行于24日再举办专家电话会议，讨论涉及中国公司的医药授权安排的美国政策前景，认为美国对源自中国的医药授权政策展望偏正面，并对创新药及生物科技持建设性看法。野村则表示，中国医药“十五五”规划突出创新与全球化，利好创新药企及CRDMO。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","SYNB","GDOC","02269","LU0181495838.USD","LU0477156953.USD","MEDX","IYF","LU0456846285.SGD","KURE","LU0072461881.USD","LNGR","LU0516422366.SGD","HBImain","LU0052750758.USD","01548","IBBJ","159992","LU0348825331.USD","BK4588","LU2456880835.USD","LU2125910500.SGD","LU0051755006.USD","IBBQ","FTXO","03347","LU0979878070.USD","LU0516423174.USD","LU0980610538.SGD","XBI","LU1366192091.USD","06821","06978","LU1880383366.USD","LU1267930227.SGD","LU1794554557.SGD","AGNG","HK0000320223.HKD","LU0029874905.USD","LU0128522744.USD","TFNS","02359","LU0307460666.USD","LU2360032135.SGD","BK4559","KCAI","BK4585","BK4504","159837","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670417524","title":"药明生物(02269)出现大手卖出15.9万股，成交价$53.05，涉资843.495万","url":"https://stock-news.laohu8.com/highlight/detail?id=2670417524","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670417524?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 11:42","pubTimestamp":1790307720,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在上午11:42出现大手卖出，成交量为15.9万，成交价为港币$53.05，涉资843.495万。至目前为止，股价升2.216%，今日最高价为$53.3，而最低价为$51.6，总成交量为435.707万股，总成交金额港币$2.296亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609253941/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609253941/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1242518931.SGD","LU0326950275.SGD","BK1610","LU0516423091.SGD","LU0823426308.USD","LU0819121731.USD","LU0052750758.USD","SG9999002463.SGD","LU0128522744.USD","LU0140636845.USD","LU0516423174.USD","LU0516422440.USD","LU0856984785.SGD","BK1576","LU1720050803.USD","LU0043850808.USD","SG9999002562.SGD","LU1880383366.USD","LU2039709279.SGD","LU0516422952.EUR","LU1688375341.USD","LU0029874905.USD","LU0320764599.SGD","BK1521","LU0051755006.USD","02269","LU0359201612.USD","LU0708995583.HKD","LU0823426480.USD","LU1242518857.USD","LU0634319403.HKD","BK1141","LU0029874061.USD","IE00B0JY6N72.USD","LU0307460666.USD","LU0128526141.USD","LU0979878070.USD","LU0456846285.SGD","BK1589","LU0327786744.USD","LU0588546209.SGD","LU3063872942.SGD","LU0456827905.SGD","LU0561508036.HKD","LU0708995153.HKD","LU0540923850.HKD","LU0320764243.SGD","KURE","LU0348825331.USD","LU0516422366.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670148064","title":"AI医疗概念股盘初多股扬升 金斯瑞生物科技（01548）领涨7.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670148064","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670148064?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 09:46","pubTimestamp":1790300777,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股AI医疗概念股盘初多股扬升，截至发稿，金斯瑞生物科技 涨7.05%，轻松健康涨1.53%，药明康德涨1.17%，药明生物涨1.16%，云顶新耀涨0.65%。另一消息面上，西南证券发布研报称，AI制药行业已历经萌芽期、发展期，自2024年起进入成熟深化的商业化验证阶段，竞争核心由模型算法转向高质量数据、实验闭环能力以及AI药物商业化兑现能力。基于AI制药处于商业化价值验证关键期，该机构建议从研发、商业化、BD三大维度把握投资机会。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992478","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0181495838.USD","LU0708995583.HKD","AGIX","HK0000306685.HKD","LU0029874905.USD","LU0043850808.USD","LU0051755006.USD","LU0359202008.SGD","LU0417516738.SGD","LU0456827905.SGD","HK0000306701.USD","BK1141","LU2039709279.SGD","AIPO","VTHR","LU0516423091.SGD","01548","01952","02661","LU0052750758.USD","LU0348827113.USD","LU1046422090.SGD","LU0588546209.SGD","LU0634319403.HKD","LU1720050803.USD","BK1589","ARTY","LU2242644610.SGD","LU0327786744.USD","LU0348825331.USD","LU2125910500.SGD","QTOC","BK1583","02269","159891","SG9999002463.SGD","LU0320764599.SGD","HK0000320223.HKD","LU0823426480.USD","LU0307460666.USD","LU1880383366.USD","KURE","CHAT","02359","LU0359201612.USD","LU1242518931.SGD","LU0029874061.USD","LU0516422952.EUR","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670411383","title":"【湾区早参】8月香港整体出口和进口货值分别上升53.0%和60.0%；深圳推动“好房子”建设提质增效","url":"https://stock-news.laohu8.com/highlight/detail?id=2670411383","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670411383?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 08:55","pubTimestamp":1790297716,"startTime":"0","endTime":"0","summary":"2026年首八个月的商品整体出口货值较2025年同期上升42.5%。同时，商品进口货值上升5.1%。董事会建议派发2026财政年度末期普通股息每股0.33港元。期内，公司应占经营溢利按年增加3%至45.906亿港元。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992472","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031HY20.USD","LU1188198961.HKD","LU0067412154.USD","KURE","LU0880133367.SGD","LU1951186391.HKD","LU1807302812.USD","LU2039709279.SGD","IE00BZ08YS42.EUR","BK1230","BK1191","IE0008369823.USD","00659","LU1008478684.HKD","01787","LU1328277881.USD","BK1198","IE0008368742.USD","BK1515","02726","LU0181495838.USD","LU0326950275.SGD","LU0244354667.USD","LU1226287529.USD","LU0072913022.USD","LU1960683339.HKD","SG9999004220.SGD","IE00B543WZ88.USD","LU1152091754.HKD","IE00BZ08YT58.USD","LU1226288170.HKD","LU0314109678.HKD","LU0501845795.SGD","LU0315179316.USD","LU1226287792.SGD","LU1226288253.USD","LU0463099449.HKD","BK1592","LU1831875114.USD","LU0828237940.HKD","IE00BZ08YR35.GBP","LU1226287875.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1152091168.USD","01093","LU1813983027.USD","BK1544","BK1521","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670352419","title":"智通港股早知道 | 监管明确险资投资港股通ETF口径 海光芯正(01191)南向持股占比升至4.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670352419","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670352419?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 07:52","pubTimestamp":1790293960,"startTime":"0","endTime":"0","summary":"预计本公司将于2026年12月31日前与相关方订立合伙协议及附属协议。 海光芯正：下半年1.6T光模块开始出货 南向持股占比升至4.2%海光芯正在9月9日至11日举行的第27届中国国际光电博览会上，展出全栈自研硅光1.6T光模块和6.4T NPO。此外，南向资金近期持续加仓，海光芯正已于今年9月7日起纳入港股通。截至目前，南向资金持有海光芯正384.44万股，占公司已发行普通股的4.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0211977185.USD","LU1226287792.SGD","LU2097828714.EUR","LU0173614495.USD","LU1152091754.HKD","01133","BK1550","LU0315179316.USD","LU1152091168.USD","FLHK","IE00B543WZ88.USD","03692","LU0326950275.SGD","LU0287142896.SGD","LU0067412154.USD","LU0708995583.HKD","KURE","BK1537","LU0871576103.HKD","IE00B031HY20.USD","LU1226287875.USD","LU1046422090.SGD","LU1008478684.HKD","LU1226288170.HKD","03933","LU2097828631.EUR","LU1206782309.USD","LU0140636845.USD","SG9999012710.SGD","VXUS","01191","LU1960683339.HKD","01093","IE00B3M56506.USD","00659","BK1170","LU0320764599.SGD","IE00B5MMRT66.SGD","IE0032431581.USD","LU1226287529.USD","02628","BK1205","BK1589","BK1521","BK4550","FDN","LU0307460666.USD","BK1230","SG9999003461.SGD","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499225","title":"深度｜中国创新药的命题：原始创新与全球重磅品种如何突围","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499225","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669499225?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 22:11","pubTimestamp":1790259093,"startTime":"0","endTime":"0","summary":"依托高效的研发效率，中国创新药在全球医药创新版图站稳脚跟，但中国医药创新发展亟待进阶，从跟随式创新进一步迈向原始创新。在业内看来，若国内创新药始终停留在管线对外输出层面，也难以培育全球重磅品种，更难以诞生具备全球商业化能力的制药巨头，中国在全球医药产业链中的竞争地位依旧受限。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609243883931116.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609243883931116.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669988174","title":"石药集团(01093)：JMT101联合奥希替尼一线治疗携带EGFR20号外显子插入突变的局部晚期或转移性非小细胞肺癌的Ⅲ期临床试验取得阳性顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2669988174","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669988174?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 20:24","pubTimestamp":1790252678,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的贝柯妥塔单抗联合奥希替尼一线治疗携带表皮生长因子受体20号外显子插入突变的局部晚期或转移性非小细胞肺癌的Ⅲ期临床试验，在预设的期中分析中达到主要终点，取得阳性顶线结果。该试验是一项随机、开放、平行对照的Ⅲ期临床试验，旨在比较该产品联合奥希替尼与铂类联合培美曲塞在上述患者一线治疗中的有效性及安全性。此外，该联合治疗方案的安全性良好。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1152091754.HKD","LU1960683339.HKD","LU1993786604.SGD","LU1226287792.SGD","KURE","LU1951186391.HKD","BK1515","BK1191","HK0000165453.HKD","LU1008478684.HKD","LU0140636845.USD","IE0008368742.USD","LU0326950275.SGD","BMED","LU1328277881.USD","LU0315179316.USD","IE00B5MMRT66.SGD","LU1226287529.USD","LU1226288253.USD","IE00BZ08YS42.EUR","LU1152091168.USD","IBBQ","LU1807302812.USD","PSYK","LU1226287875.USD","LU0072913022.USD","IBBJ","BK1521","LU0314109678.HKD","IE0008369823.USD","LU0880133367.SGD","SG9999004220.SGD","LU0067412154.USD","LU1226288170.HKD","MDTX","01093","IE00B543WZ88.USD","LU0501845795.SGD","IE00BZ08YR35.GBP","LU1813983027.USD","LU2039709279.SGD","IE00B031HY20.USD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180766578","title":"石药集团：Becotatug（JMT101）联合奥希替尼III期试验取得积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1180766578","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180766578?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 20:09","pubTimestamp":1790251777,"startTime":"0","endTime":"0","summary":"石药集团宣布，Becotatug（JMT101）与奥希替尼联合用药的III期临床试验已获得积极的顶线结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1152091168.USD","LU0314109678.HKD","LU1226287529.USD","LU1328277881.USD","LU1960683339.HKD","IE00B543WZ88.USD","IE0008369823.USD","BK1521","BK1515","LU1807302812.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU0140636845.USD","LU1008478684.HKD","LU0067412154.USD","IE00B5MMRT66.SGD","SG9999004220.SGD","IE00B031HY20.USD","LU1152091754.HKD","LU2039709279.SGD","IE0008368742.USD","HK0000165453.HKD","LU1813983027.USD","LU1226288253.USD","LU1226287792.SGD","LU0315179316.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","BK1191","LU0501845795.SGD","LU1993786604.SGD","KURE","01093","LU0072913022.USD","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1226288170.HKD","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669152465","title":"石药集团(01093.HK)：注射用多西他赛(白蛋白结合型)(HB1801)用于治疗晚期乳腺癌的Ⅲ期临床试验在中国正式启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2669152465","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669152465?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 17:02","pubTimestamp":1790240561,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1521","IE00B031HY20.USD","BK1515","LU0501845795.SGD","LU1226288253.USD","BK1191","LU1993786604.SGD","IE0008368742.USD","SG9999004220.SGD","LU2039709279.SGD","LU0314109678.HKD","LU1226287792.SGD","IE0008369823.USD","LU0880133367.SGD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","LU0067412154.USD","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1152091168.USD","IE00B5MMRT66.SGD","LU1008478684.HKD","LU1226287529.USD","LU1226288170.HKD","LU1960683339.HKD","LU1807302812.USD","LU0140636845.USD","LU1328277881.USD","IE00B543WZ88.USD","KURE","LU1152091754.HKD","HK0000165453.HKD","LU0072913022.USD","LU1226287875.USD","01093","LU1813983027.USD","LU0315179316.USD","LU1951186391.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669451177","title":"生物医药板块全线走低 诺诚健华（09969）跌10.48% 机构指行业需求尚未明显回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2669451177","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669451177?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 13:36","pubTimestamp":1790228201,"startTime":"0","endTime":"0","summary":"金吾财讯 |  港股生物医药板块午后全线走低，截至发稿，诺诚健华 跌10.48%，荣昌生物跌7.99%，复宏汉霖跌7.68%，康诺亚-B跌5.86%，再鼎医药跌5.32%，君实生物跌4.53%，金斯瑞生物科技跌4.21%，康方生物跌3.54%，科伦博泰生物跌3.11%，泰格医药跌2.35%，药明生物跌1.80%，百济神州跌1.56%，药明合联跌1.12%。消息面上，国盛证券发布研报称，医药行业需求尚未明显回暖，降本增效、费用精细化管理已成为利润端的重要支撑。下半年关注流感旺季带来的阶段性需求催化。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992441","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518857.USD","BK1583","XBI","09926","LU0516422366.SGD","LU1303224171.USD","SG9999002463.SGD","LU0828237510.HKD","09688","02268","01877","SG9999014674.SGD","LU2039709279.SGD","06160","LU0456846285.SGD","BK1141","BK1515","LU1242518931.SGD","LU1961090484.USD","399441","02162","LU1880383366.USD","LU1719994722.HKD","688428","LU0348783233.USD","LU0540923850.HKD","LU0856984785.SGD","06990","BK4581","LU0140636845.USD","09969","BK1576","LU1770034418.SGD","02696","LU3063872942.SGD","SG9999002562.SGD","LU2328871848.SGD","02269","03347","09995","LU2399975544.HKD","LU0561508036.HKD","01548","LU0516423174.USD","161726","KURE","LU0348825331.USD","LU0348766576.USD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669456110","title":"信达生物(01801)出现大手卖出10.75万股，成交价$100.0，涉资1.075千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2669456110","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669456110?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 11:48","pubTimestamp":1790221680,"startTime":"0","endTime":"0","summary":"[大手成交]信达生物(01801)在上午11:48出现大手卖出，成交量为10.75万，成交价为港币$100.0，涉资1.075千万。至目前为止，股价跌2.515%，今日最高价为$102.6，而最低价为$99.4，总成交量为354.618万股，总成交金额港币$3.562亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609243163/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609243163/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1831875114.USD","LU2097828557.USD","LU2097828714.EUR","LU0244354667.USD","LU2097828474.EUR","KURE","LU0607220059.USD","LU0326950275.SGD","LU0149534421.HKD","LU0455707207.USD","LU1188198961.HKD","BK1583","BK1589","LU0502904849.HKD","LU2097828805.USD","LU2488822045.USD","BK1161","LU2328871848.SGD","01801","LU2242644610.SGD","LU1969619763.USD","LU2097828631.EUR","HK0000165453.HKD","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669226458","title":"药明生物(02269)出现大手卖出10.05万股，成交价$52.25，涉资525.112万","url":"https://stock-news.laohu8.com/highlight/detail?id=2669226458","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669226458?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 09:45","pubTimestamp":1790214300,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在上午09:45出现大手卖出，成交量为10.05万，成交价为港币$52.25，涉资525.112万。至目前为止，股价跌0.947%，今日最高价为$52.95，而最低价为$52.05，总成交量为208.093万股，总成交金额港币$1.094亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609241435/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609241435/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0320764243.SGD","LU0326950275.SGD","LU0348735423.USD","LU0516423174.USD","LU0561508036.HKD","BK1141","LU1242518857.USD","LU0856984785.SGD","BK1589","LU0456827905.SGD","LU1880383366.USD","BK1610","LU0516423091.SGD","LU0456846285.SGD","LU0140636845.USD","LU0128522744.USD","IE00B0JY6N72.USD","LU0043850808.USD","LU0708995583.HKD","LU0359201612.USD","LU1688375341.USD","LU0029874905.USD","LU0348825331.USD","KURE","LU0327786744.USD","LU0979878070.USD","LU0516422952.EUR","LU0181495838.USD","LU0823426308.USD","LU0708995153.HKD","LU0819121731.USD","LU0634319403.HKD","LU3063872942.SGD","SG9999002463.SGD","LU1794554557.SGD","LU0572944931.SGD","LU0307460666.USD","LU0052750758.USD","SG9999002562.SGD","LU1720050803.USD","LU0128526141.USD","LU0348827113.USD","LU0417516902.SGD","LU0359202008.SGD","LU0823426480.USD","BK1576","LU0320764599.SGD","LU0417516738.SGD","LU0540923850.HKD","02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669929430","title":"【券商聚焦】国金证券：跨赛道巨头竞速AI4S制药，板块成长趋势进一步确立","url":"https://stock-news.laohu8.com/highlight/detail?id=2669929430","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669929430?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 09:05","pubTimestamp":1790211914,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国金证券研究指，Anthropic在旧金山湾区建立湿实验室，礼来TuneLab一日新增3家供应商，湿实验验证环节的提速竞赛加剧。中国将生物医药提升至新兴支柱产业，FDA试行IND滚动提交。该机构认为，目前态势明确：跨赛道巨头竞速AI4S制药，政府与监管共同提速创新，订单增量率先落在CXO上游，板块成长趋势进一步确立。风险提示：汇兑风险，国内外政策风险，投融资周期波动风险，并购整合不及预期的风险。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992370","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","LU0463099449.HKD","KURE","IE00BPRC5H50.USD","06821","01530","LU1969619763.USD","06160","BK1197","BK1593","BK1141","02367","LU0348784397.USD","LU0348825331.USD","LU0640798160.USD","02228","BK0028","09688","LU0417516902.SGD","IE00B543WZ88.USD","01789","09926","BK1583","HK0000165453.HKD","LU0348783233.USD","BK1588","01477","LU0348767384.USD","LU2476274720.SGD","LU1188198961.HKD","LU0828237510.HKD","600109","LU1770034418.SGD","LU0417516571.SGD","03933","BK0276","02196","BK1617","LU1794554557.SGD","01099","BK1161","IE00B3M56506.USD","BK1574","LU0307460666.USD","LU0326950275.SGD","KCE","SG9999014674.SGD","BK1515","BK0201","LU0228659784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430903","title":"【券商聚焦】国金证券：中国双抗/ADC/小核酸具全球竞争力，有望催化创新药新一轮出海与估值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430903","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669430903?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 09:05","pubTimestamp":1790211910,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国金证券研究指，2026 WCLC首尔召开，中国创新药密集登场：康方依沃西一线NSCLC头对头优效帕博利珠，PD-1/VEGF双抗领跑IO2.0；翰森/宜联B7-H3ADC进全体会场，ADC向前线+围手术期迁移；KRAS G12D、HER2、EGFR耐药等精准治疗破局。中国双抗/ADC/小核酸具全球竞争力，数据国际领先，有望催化创新药新一轮出海与估值重估。风险提示：新药研发失败风险；研发进度低于预期风险；药品降价风险。","market":"other","thumbnail":"https://static.szfiu.com/news/20250110/YzMzOTE1NTA2MzA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/YzMzOTE1NTA2MzA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992369","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877","LU1152091754.HKD","02269","09926","09995","LU1993786604.SGD","LU1226287792.SGD","LU0348735423.USD","LU0708995583.HKD","KURE","159992","SG9999002562.SGD","BK1515","HK0000165453.HKD","LU0828237510.HKD","LU3063872942.SGD","600109","LNGR","LU1719994722.HKD","LU0359202008.SGD","LU0516423091.SGD","06978","LU0039217434.USD","LU1251922891.USD","06185","IE00B5MMRT66.SGD","LU0128526141.USD","LU0315179316.USD","LU0029874061.USD","LU0348784397.USD","LU1226288253.USD","LU0348766576.USD","09688","LU0417516902.SGD","LU1152091168.USD","IBBQ","LU0314109678.HKD","LU2097828805.USD","02616","LU0320764599.SGD","MEDX","01093","02142","LU1770034418.SGD","LU2476274720.SGD","06160","01177","01801","KCE","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488353","title":"港股医药实力抗跌！CXO再扛旗，核心ETF（159137）逆市收红，金斯瑞创5年新高！两个问题引发关注……","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488353","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669488353?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 19:17","pubTimestamp":1790162220,"startTime":"0","endTime":"0","summary":"AI制药产业链上游CXO全天强势，百奥赛图-B领涨近5%，金斯瑞生物科技再涨3.21%创5年新高！港股通医疗ETF华宝标的指数AI制药含量近70%，盘中冲高1.4%，收涨0.1%。图：港股通创新药ETF华宝近6月走势近期港股创新药链相对强势，回顾行情结构，两个问题引发关注：其一，AI制药热度走高，为什么CXO涨势更优。港股通创新药ETF华宝：标的指数100%布局创新药研发类公司，7成仓位押注创新药研发龙头。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-23/doc-inisvivx8562452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FDN","BK4550","159137","BK4585","CXO","BK4588","KURE","159718","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669027001","title":"【天风医药杨松团队|公司点评】信达生物：肿瘤与综合产品线双轮驱动，业绩保持强劲增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2669027001","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669027001?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 17:37","pubTimestamp":1790156220,"startTime":"0","endTime":"0","summary":"业绩保持强劲增长，经营效率持续改善2026H1公司实现总收入86.18亿元，同比增长44.8%，其中产品收入82.01亿元，同比增长56.7%，肿瘤与综合产品线共同驱动收入增长。过去10个月公司与武田、礼来、辉瑞达成多项战略合作，合作管线超20款，总价值约340亿美元。2026H1公司研发开支16.84亿元，对应研发费用率19.54%，同比增加2.59 pct；销售及市场推广开支32.36亿元，对应销售费用率37.55%，同比减少2.35 pct；行政及其他开支4.94亿元，对应管理费用率5.73%，同比减少1.70 pct。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-23/doc-inisviwc1134450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1969619763.USD","BK1574","LU0502904849.HKD","01801","BK1515","LU0149534421.HKD","BK1589","LU2097828805.USD","LU1831875114.USD","BK1583","LU2097828474.EUR","LU2328871848.SGD","BK1161","HK0000165453.HKD","LU2097828631.EUR","LU2488822045.USD","LU0463099449.HKD","LU0455707207.USD","LU2097828557.USD","LU0607220059.USD","LU2242644610.SGD","KURE","LU1188198961.HKD","LU0326950275.SGD","159938","LU2097828714.EUR","LU0244354667.USD","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669050551","title":"百济神州(06160)出现大手买入2.74万股，成交价$217.4，涉资595.676万","url":"https://stock-news.laohu8.com/highlight/detail?id=2669050551","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669050551?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 15:34","pubTimestamp":1790148840,"startTime":"0","endTime":"0","summary":"[大手成交]百济神州(06160)在下午03:34出现大手买入，成交量为2.74万，成交价为港币$217.4，涉资595.676万。至目前为止，股价跌0.184%，今日最高价为$221.4，而最低价为$217.0，总成交量为199.274万股，总成交金额港币$4.364亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609235122/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609235122/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06160","BK1583","LU0228659784.USD","LU0588546209.SGD","BK1161","BK0239","BK1588","LU0307460666.USD","LU2328871848.SGD","BK1500","KURE","LU1251922891.USD","LU1303224171.USD","LU1969619763.USD","LU1719994722.HKD","LU0828237510.HKD","LU1770034418.SGD","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669174543","title":"A股医药板块全线爆发，发生了什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2669174543","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669174543?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 11:25","pubTimestamp":1790133902,"startTime":"0","endTime":"0","summary":"长线价值可期","market":"hk","thumbnail":"https://img3.gelonghui.com/2de79-53cbdbcc-e37e-4084-bfb6-5900b95caac1.jpg?guru_height=716&guru_width=1280&guru_size=127020","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/2de79-53cbdbcc-e37e-4084-bfb6-5900b95caac1.jpg?guru_height=716&guru_width=1280&guru_size=127020"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6781668","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669517917","title":"康方生物(09926)出现大手卖出6.9万股，成交价$100.0，涉资690万","url":"https://stock-news.laohu8.com/highlight/detail?id=2669517917","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669517917?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 10:00","pubTimestamp":1790128800,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在上午10:00出现大手卖出，成交量为6.9万，成交价为港币$100.0，涉资690万。至目前为止，股价升4.484%，今日最高价为$100.3，而最低价为$96.15，总成交量为280.598万股，总成交金额港币$2.753亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609232605/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609232605/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1961090484.USD","LU2476274720.SGD","LU0417516571.SGD","BK1574","LU1794554557.SGD","IE00BPRC5H50.USD","LU0348827113.USD","LU0348825331.USD","LU2399975544.HKD","LU2778985437.USD","LU2476274308.USD","LU2488822045.USD","LU0417516738.SGD","LU0348783233.USD","LU0348735423.USD","LU0540923850.HKD","LU0348766576.USD","BK1161","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0348784397.USD","LU0348767384.USD","09926","LU0634319403.HKD","LU0561508036.HKD","LU0417516902.SGD","LU1720050803.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669179352","title":"国金证券：中国创新药密集登场成肺癌前沿焦点 ADC治疗线数持续前移","url":"https://stock-news.laohu8.com/highlight/detail?id=2669179352","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669179352?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 09:50","pubTimestamp":1790128202,"startTime":"0","endTime":"0","summary":"国金证券主要观点如下：2026 WCLC大会召开，中国创新药密集登场，成为全球肺癌前沿研发的焦点2026年WCLC于9月12日至15日在韩国首尔召开，作为全球肺癌领域最具影响力的年度学术会议之一，本届会议集中呈现了晚期NSCLC、晚期驱动基因阳性NSCLC、复发/难治SCLC、围手术期肺癌等领域的关键进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","KURE","BK0188","BK0183","BK0012","600109","BK0201","BK0276"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}